BakerIDI Heart and Diabetes Institute,
Epigenomic Medicine,
Baker IDI Heart and Diabetes Institute,
Epigenomic Medicine, Baker IDI Heart and Diabetes Institute,
Epigenomic Medicine, BakerIDI Heart and Diabetes Institute
Tom C. Karagiannis has not added Biography.
If you are Tom C. Karagiannis and would like to personalize this page please email our Author Liaison for assistance.
Epigenetic changes activate widespread signals in response to double-strand breaks.
Cancer biology & therapy Jul, 2004 | Pubmed ID: 15136760
Plasmid DNA breakage by decay of DNA-associated Auger electron emitters: approaches to analysis of experimental data.
Radiation research Jul, 2004 | Pubmed ID: 15222798
siRNAs: mechanism of RNA interference, in vivo and potential clinical applications.
Cancer biology & therapy Nov, 2004 | Pubmed ID: 15539939
Radio- and chemo-sensitization of human erythroleukemic K562 cells by the histone deacetylase inhibitor Trichostatin A.
Hellenic journal of nuclear medicine Sep-Dec, 2004 | Pubmed ID: 15841297
RNA interference and potential therapeutic applications of short interfering RNAs.
Cancer gene therapy Oct, 2005 | Pubmed ID: 15891770
The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X.
Cancer biology & therapy Jul, 2005 | Pubmed ID: 16082178
The paradox of histone deacetylase inhibitor-mediated modulation of cellular responses to radiation.
Cell cycle (Georgetown, Tex.) Feb, 2006 | Pubmed ID: 16418577
DNA targeted UVA photosensitization: characterization of an extremely photopotent iodinated minor groove binding DNA ligand.
Journal of photochemistry and photobiology. B, Biology Jun, 2006 | Pubmed ID: 16488619
Radioimmunotherapy: Principles, current trends and future directions.
Hellenic journal of nuclear medicine Jan-Apr, 2004 | Pubmed ID: 16868640
Receptor-mediated DNA-targeted photoimmunotherapy.
Cancer research Nov, 2006 | Pubmed ID: 17079478
Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
Hellenic journal of nuclear medicine May-Aug, 2007 | Pubmed ID: 17684582
Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer.
Epigenetics : official journal of the DNA Methylation Society Jul-Sep, 2006 | Pubmed ID: 17965606
The epigenetic modifier, valproic acid, enhances radiation sensitivity.
Epigenetics : official journal of the DNA Methylation Society Jul-Sep, 2006 | Pubmed ID: 17965607
Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies.
Hellenic journal of nuclear medicine Sep-Dec, 2007 | Pubmed ID: 18084655
Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments.
Cell cycle (Georgetown, Tex.) Feb, 2008 | Pubmed ID: 18239454
gamma-radiation-induced gammaH2AX formation occurs preferentially in actively transcribing euchromatic loci.
Cellular and molecular life sciences : CMLS Jan, 2010 | Pubmed ID: 19859659
GammaH2AX as a molecular marker of aging and disease.
Epigenetics : official journal of the DNA Methylation Society Feb, 2010 | Pubmed ID: 20150765
Methylproamine protects against ionizing radiation by preventing DNA double-strand breaks.
Mutation research Oct, 2010 | Pubmed ID: 20732333
Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes.
Aging Oct, 2010 | Pubmed ID: 20930262
Protection by methylproamine of irradiated human keratinocytes correlates with reduction of DNA damage.
International journal of radiation biology Mar, 2011 | Pubmed ID: 21087168
Genetic and epigenetic events in diabetic wound healing.
International wound journal Feb, 2011 | Pubmed ID: 21159125
Epigenome targeting by probiotic metabolites.
Gut pathogens , 2010 | Pubmed ID: 21172038
Double-strand breaks and the concept of short- and long-term epigenetic memory.
Chromosoma Apr, 2011 | Pubmed ID: 21174214
Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks.
Genome integrity , 2011 | Pubmed ID: 21261999
Effects of oral intake of water in patients with oropharyngeal dysphagia.
BMC geriatrics , 2011 | Pubmed ID: 21356121
Photosensitization by iodinated DNA minor groove binding ligands: Evaluation of DNA double-strand break induction and repair.
Journal of photochemistry and photobiology. B, Biology May, 2011 | Pubmed ID: 21440453
Molecular model of naphthalene-induced DNA damage in the murine lung.
Human & experimental toxicology Jan, 2012 | Pubmed ID: 21508073
Histone deacetylase inhibitors augment doxorubicin-induced DNA damage in cardiomyocytes.
Cellular and molecular life sciences : CMLS Dec, 2011 | Pubmed ID: 21584806
Chromatin modifying agents - the cutting edge of anticancer therapy.
Drug discovery today Jul, 2011 | Pubmed ID: 21664485
Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis.
Genes & nutrition Sep, 2011 | Pubmed ID: 21953375
Potential non-oncological applications of histone deacetylase inhibitors.
American journal of translational research , 2011 | Pubmed ID: 22046487
Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease.
Epigenetics : official journal of the DNA Methylation Society Dec, 2011 | Pubmed ID: 22139576
Utility of γH2AX as a Molecular Marker of DNA Double-Strand Breaks in Nuclear Medicine: Applications to Radionuclide Therapy Employing Auger Electron-Emitting Isotopes.
Current radiopharmaceuticals Jan, 2011 | Pubmed ID: 22191615
Influence of Natural and Synthetic Histone Deacetylase Inhibitors on Chromatin.
Antioxidants & redox signaling Feb, 2012 | Pubmed ID: 22229817
Histone deacetylases and their role in asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma Mar, 2012 | Pubmed ID: 22233225
Li-Jeen Mah1,2,
Raja S. Vasireddy1,2,3,
Michelle M. Tang1,3,
George T. Georgiadis1,
Assam El-Osta2,3,
Tom C. Karagiannis1,2
1Epigenomic Medicine, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct,
2Department of Pathology, The University of Melbourne,
3Epigenetics in Human Health and Disease, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct
Michelle M. Tang1,2,
Li-Jeen Mah1,3,
Raja S. Vasireddy1,2,3,
George T. Georgiadis1,
Assam El-Osta2,3,
Simon G. Royce3,4,5,
Tom C. Karagiannis1,3
1Epigenomic Medicine, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct,
2Epigenetics in Human Health and Disease, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct,
3Department of Pathology, The University of Melbourne,
4Department of Allergy and Immunology, Murdoch Children's Research Institute, Royal Children's Hospital,
5Department of Pediatrics, The University of Melbourne
Haloom Rafehi1,2,
Christian Orlowski1,2,3,
George T. Georgiadis1,
Katherine Ververis1,4,
Assam El-Osta2,3,
Tom C. Karagiannis1,2
1Epigenomic Medicine, BakerIDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct,
2Department of Pathology, The University of Melbourne,
3Epigenetics in Human Health and Disease, BakerIDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct,
4Department of Anatomy and Cellular Biology, The University of Melbourne
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados